ACESION PHARMA ApS: Financial statements 2012
CVR: 34083738
Source: annual report 2012, Danish Business Authority
15/12/2011 – 31/12/2012
ACESION PHARMA ApS (CVR 34083738) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK -1,313,935 and a net result of DKK -2,068,513. Equity in the 2012 report amounted to DKK 1,951,483. The solvency ratio was 74.2%.
- Gross Profit
- DKK -1,313,935
- Profit/Loss
- DKK -2,068,513
- Equity
- DKK 1,951,483
- Total Assets
- DKK 2,629,402
Keep an eye on ACESION PHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout ACESION PHARMA ApS
ACESION PHARMA ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2011. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Anders Gaarsdal Holst. The board consists of Jørgen Søberg Petersen (chair), Benjamin Bruno Thorner, Nik Economopoulos and Timothy Michael Shannon. The company's owners include Novo Holdings A/S, Canaan XII L.P. and Alpha Wave Ventures II, LP. The company has 14 employees (2018). In 2025, the company reported a net result of DKK -59,597,000 compared with DKK -43,033,000 the year before. Equity in the 2025 report amounted to DKK 276,067,000.